Featured CME Programs

2025 Practice-Changing Updates In Bladder, Kidney & Prostate Cancer

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this program brings together a distinguished team of thought leaders in genitourinary cancers to present the latest strategies for managing localized and advanced bladder, kidney, and prostate cancers.

With rapid advances in systemic therapies, surgical techniques, and radiation technologies, clinicians are navigating an increasingly complex treatment landscape. The rapid entry of novel agents into the non-muscle invasive bladder cancer space is creating new therapeutic decision points. At the same time, advances in radiation oncology technologies and techniques continue to refine precision and efficacy. This CME program focuses on how to effectively integrate these innovations into everyday practice.

Through expert-led lectures, panel discussions, and case-based sessions, participants will gain practical insights they can apply directly in the clinical trenches.

PROGRAM DATE: Thursday, October 23, 2025

TIMES: 

5:45–7:00 pm EST Check-In and Reception
(Buffet opens at 6:30)
7:00–9:00 pm EST CME & Dinner

LOCATION: 

Philadelphia Marriott Old City 
One Dock Street 
Philadelphia, PA 19106

Registration:   https://www.eeds.com/live/467880

PROGRAM DIRECTORS

Alexander Kutikov, MD, FAC
Associate Professor, 
Chair and Professor, Department of Urology
Roberta R. Scheller Chair in Urologic Oncology
Fox Chase – Temple Urologic Institute Provider
Fox Chase Cancer Center 

Fern M. Anari, MD
Assistant Professor, Department of Hematology/Oncology
Fox Chase Cancer Center

LEARNING OBJCTIVES: 
•    Explain emerging systemic therapies for bladder, kidney, and prostate cancer 
•    Highlight the rapid entry of novel agents into the non-muscle invasive bladder cancer treatment space 
•    Discuss the newest data and evolving approaches in radiation oncology for localized and advanced genitourinary malignancies
 

INTENDED AUDIENCE: This program is designed for urologists; medical, radiation and surgical oncologists; radiologists; primary care physicians; fellows/residents/students; nurses; nurse practitioners; advanced practice providers; and all healthcare professionals involved in the care of patients with bladder, kidney, or prostate cancer.

ACCREDITATION STATEMENT:  The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

DESIGNATION STATEMENT: The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.

INQUIRIES: Lucía Tono, PhD, MEd 215-728-3797 
[email protected]

EXHIBITOR INFORMATION: Contact Lisa Bailey to learn about opportunities to exhibit at this event at at 215-872-5846 or [email protected].

Advances In Thoracic Oncology Conferences

The rapid evolution of information surrounding the management of thoracic malignancies presents ongoing challenges for physicians tasked with selecting the most appropriate treatment strategies. To address this, Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education are offering a comprehensive course focused on the latest advances in the detection, imaging, diagnosis, staging, treatment, and research of non-small cell lung cancer (NSCLC). This course is designed to provide practical, up-to-date insights for anyone involved in the care of lung cancer patients or seeking a current overview of the field.

PROGRAM DATE: Saturday, November 1, 2025

TIMES: 

7:00 am EST Check-In and Breakfast
7:30–3:00 pm EST CME Program

LOCATION: 

Philadelphia Marriott Old City 
One Dock Street 
Philadelphia, PA 19106

Registration: https://www.eeds.com/live/810168

 

PROGRAM DIRECTOR

Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology
Professor, Department of Hematology/Oncology
Co-Director, Immune Monitoring Facility
Gloria and Edmund M. Dunn Chair in Thoracic Oncology
Fox Chase Cancer Center 
 

EDUCATIONAL OBJECTIVES
1.    Identify MET IHC-positive tumors and select appropriate treatment strategies.
2.    Select patients with early-stage NSCLC who are appropriate candidates for neoadjuvant therapy.
3.    Determine the optimal frontline treatment for patients with advanced EGFR-mutated NSCLC.
 

INTENDED AUDIENCE:  This course is appropriate for primary care and family medicine physicians; medical, surgical, and radiation oncologists; thoracic and general surgeons; pulmonologists; pathologists; radiologists; fellows/residents/students; nurses; physician assistants; advanced practice providers; and researchers involved in the management of patients with lung cancer and thoracic malignancies.

ACCREDITATION STATEMENT:  The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

DESIGNATION STATEMENT:  The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 5 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.

INQUIRIES: Lucía Tono, PhD, MEd 215-728-3797 
[email protected]

EXHIBITOR INFORMATION: Learn more about opportunities to exhibit at this event or contact Lisa Bailey for more information at 215-872-5846 or [email protected].

24th Annual Highlights of the 2025 San Antonio Breast Cancer Symposium

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this educational program is designed to help clinicians translate key findings from the 2025 San Antonio Breast Cancer Symposium into practical applications for patient care. The course will cover emerging advances in the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease, along with new strategies to optimize current therapies.

PROGRAM DATE: Thursday, January 15, 2026

TIMES: 

5:45–7:00 pm EST Check-In, Reception and Poster Session (Buffet opens at 6:30)
7:00–9:00 pm EST CME & Dinner

LOCATION: 

Philadelphia Marriott Old City 
One Dock Street 
Philadelphia, PA 19106

Registration:

Coming soon

PROGRAM DIRECTOR

Angela Jain, MD
Associate Professor, Department of Hematology/Oncology;
Interim Chief, Division of Breast Medical Oncology
Clinical Director, GYN/Well Women's Health Clinical Service Line
Chief, Division of Gynecologic Medical Oncology;
Fox Chase Cancer Center 
 

INTENDED AUDIENCE: The program is designed for medical, surgical, and radiation oncologists; gynecologists; radiologists; fellows; residents; medical school students; advanced practice providers; nurses; and healthcare professionals involved in the treatment of patients with breast cancer.

ACCREDITATION STATEMENT: The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

DESIGNATION STATEMENT: The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 2 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.

INQUIRIES: Lucía Tono, PhD, MEd 215-728-3797 
[email protected]

EXHIBITOR INFORMATION: Learn more about opportunities to exhibit at this event or contact Lisa Bailey for more information at 215-872-5846 or [email protected].

Resize Text

Disclosure Policy

It is the policy of the Temple Health Office for Continuing Medical Education to ensure that all sponsored continuing medical education activities are independently designed and produced and include content that is valid, objective, balanced, free of commercial bias and in the best interest to the public. Temple Health policy requires everyone in a position to control the content of an educational activity to disclose all financial relationships with ineligible companies and to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Temple Health Office for Continuing Medical Education has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to the activity.